Mauna Kea Technologies passes another key regulatory milestone on its ambitious product roadmap, positioning Cellvizio as a key technology to...
Cellvizio® Now CE Marked for Use During Robotic-Assisted Surgery
read more
Search Results
Mauna Kea Technologies reports H1 financial results
Click to read more
Mauna Kea Technologies Reports First Half 2017 Financial Results
Results reflect strategic focus on transition to Cellvizio pay-per-use business model in the U.S. Mauna Kea Technologies will host a conference call...
Cook Medical Announces Commercial Launch of Cellvizio for Urology
Cook Urology to market private-labeled version of Cellvizio globally Paris and Boston, September 05, 2017 – Mauna Kea Technologies (Euronext:...
Strong Presence of Cellvizio at the OESO 14th World Conference, September 2017
See the complete press release
Mauna Kea Technologies Receives Specific U.S. FDA 510(K) Clearance for use of Cellvizio during Robotic-Assisted Surgery
Robotic-assisted surgery is one of the fastest growing surgical categories worldwide Key milestone in the Cellvizio product development roadmap,...
Peer-Reviewed Publication of Key Multicenter Randomized Controlled Trial Demonstrating Improved Early Stomach Cancer Detection with Cellvizio
Click to read complete Press Release
Mauna Kea Technologies Reports First Half 2017 Sales
Click to read more
Mauna Kea Technologies’ company overview at the JMP Securities 2017 Life Sciences Conference
Watch our corporate update with Sacha Loiseau, Ph.D., Founder and CEO presenting Mauna Kea Technologies’ company overview at the JMP...
Mauna Kea Technologies reports full year 2016 financial results and highlights 2017 key priorities
Click to read
Presentation of New Data Demonstrating the Assessment by Cellvizio of Acute Lung Rejection Following Transplant
Data Presented at the 2017 American Thoracic Society International Conference Paris, May 23, 2017 – 5.45 PM CET – Mauna Kea Technologies...
Strong presence of Cellvizio platform at major medical meetings focused on Gastroenterology
Click to read more